FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
LAist1h
Norovirus is still spreading in LA County. Here’s what you should know
California’s peak stomach flu season is expected to continue to April. Hand sanitizers don't kill the illness, which spreads easily from person-to-person.
NOLA.com6h
Get Back in the Game: Managing Knee Pain with ZILRETTA®
For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...
ConsumerAffairs11h
La Fiesta bread crumbs recalled for undeclared allergen
La Fiesta Food Products has issued a recall for 8 oz. packages of La Fiesta brand Unseasoned Bread Crumbs (Pan Rayado) and ...
GlobalData on MSN12h
FDA grants 510(k) clearance to Roche’s Tina-quant molarity assay
Clinicians and laboratory professionals can rely on molar unit measurements to know the Lp(a) particle numbers.
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Takeaways from RFK Jr.’s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two ...